135results about How to "Dosing is convenient" patented technology

The invention relates to the improvement in the treatment of certain neural disorders / diseases, such as Parkinson's disease and other motor disorders. The invention relates to drug compositions and dosage forms comprising said drug composition; methods of manufacturing the drug compositions and dosage forms; and methods of treatment, comprising administering the drug composition and dosage form to an individual. In certain embodiments, the drug compositions and dosage forms comprise carbidopa and levodopa in a formulation suitable for once-daily administration.

Pharmaceutical dosage forms for oral administration to a patient for the treatment of diabetes, comprising insulin and a delivery agent that facilitates insulin transport in a therapeutically effective amount to the bloodstream and that result in a lower incidence of vascular diseases associated with the repeated administration of insulin are disclosed. Also disclosed is a method of attenuating the undesirable incidence of diseases associated with chronic dosing of insulin is provided whereby the oral administration to a patient of insulin along with a suitable delivery agent that facilitates the absorption of insulin from the gastrointestinal tract of the patient in a therapeutically effective amount, for treatment of diabetes.

The invention relates to the improvement in the treatment of certain neural disorders / diseases, such as Parkinson's disease and other motor disorders. One aspect of the invention relates to drug compositions and dosage forms comprising said drug composition. Another aspect of the invention relates to methods of manufacturing the drug compositions and dosage forms. Another aspect of the invention relates to methods of treatment, comprising administering the drug composition and dosage form to an individual.

The invention relates to the improvement in the treatment of certain neural disorders / diseases, such as Parkinson's disease and other motor disorders. One aspect of the invention relates to drug compositions and dosage forms comprising said drug composition. Another aspect of the invention relates to methods of manufacturing the drug compositions and dosage forms. Another aspect of the invention relates to methods of treatment, comprising administering the drug composition and dosage form to an individual.

The present invention relates to active agent delivery systems and more specifically to compositions that comprise amino acids, as single amino acids or peptides, covalently attached to active agents and methods for administering conjugated active agent compositions.

The present invention relates to active agent delivery systems and more specifically to compositions that comprise amino acids, as single amino acids or peptides, covalently attached to active agents and methods for administering conjugated active agent compositions.

The invention belongs to the technical field of a limestone / gypsum wet flue gas desulfurization technology, and particularly relates to an additive for strengthening a wet flue gas desulfurization technology, which comprises the following components in percentage by mass: 35-45% of mixed organic acid, 5-10% of organic acid salt, 6-9% of surfactant, 1-6% of heavy metal salt and 35-45% of dirt dispersion agent; and the mixed organic acid comprises adipic acid, wherein the percentage of mass of the adipic acid in the mixed organic acid is not less than 50%. The additive can be added and used for strengthening the wet flue gas desulfurization technology, improve the desulfurization efficiency of a system, reduce the energy consumption, strengthen oxidization, improve the limestone quality and restrain system scaling, and accordingly, the purposes of energy conservation, consumption reduction and waste recycling are realized.

This invention relates to an oil-soluble cationic broad-spectrum temporary blocking agent for well drilling fluid. The oil-soluble cationic broad-spectrum temporary blocking agent comprises: oil-soluble materials 50-74%, SBS triblock copolymer 0.2-0.44%, epoxypropylbenzyl di(stearamide ethyl) ammonium salt 0.50-0.89%, cationic surfactant imidazoline 0.62-0.96%, dibenzyl-di(stearamide ethyl) ammonium salt 0.62-0.96%, carboxymethyl cellulose or hydroxyethyl cellulose 0.17-0.84$, CaCl2 0.2-0.25%, and water as balance. The oil-soluble materials include residue asphalt (softening point = 51-55 deg.C), semi-oxidized asphalt (softening point = 57-65 deg.C), ethylene pyrolysis coal tar pitch (softening point = 47-52 deg.C), propane-removed asphalt (softening point = 70-77 deg.C), extracted asphalt (softening point = 105-120 deg.C), and 100# heavy oil asphalt (softening point = 47-54 deg.C) at a weight ratio of 1:(1.88-2.5):(1.25-1.88):(3.12-3.75):(2.5-3.12):(1.5-2). The oil-soluble cationic broad-spectrum temporary blocking agent has such advantages as high oil solubility, high softening degree, wide softening point range, strong positive electricity, high lubricity, good fluid-loss inhibitive effect, high recovery rate of core permeability, low temporary blocking depth, high strength, good de-blocking effect, no pollution, low labor intensity, little influence on well drilling fluid construction performance, and simple process.

The invention belongs to the technical field of a limestone-gypsum wet-method flue gas desulfuration process and relates to a multifunctional composite additive for a wet-method flue gas desulfuration process and a using method thereof. The composite additive comprises the following components in percentage by mass: 31 to 45 percent of nylon acid, 31 to 45 percent of sodium humate, 6 to 9 percentof organic silicon defoaming agent, 2 to 5 percent of potassium formate, 2 to 5 percent of manganese sulfate and 2 to 5 percent of p-hydroxybenzoic acid. The composite additive can promote the dissolution of the limestone and reduce the using amount of the limestone, has an enhancement factor for improving an absorption reaction of sulfur dioxide (SO2), accelerates the migration speed of SO2 gas liquid, promotes the adsorption reaction of the SO2 in a liquid membrane, inhibits the soft scales of calcium sulfate (CaSO3) from generating, improves the pH value buffer capacity of limestone slurry, slows down the reducing speed of the pH value in the process of absorbing the SO2 by the desulfuration slurry continuously, and achieves the effect of avoiding bubbling and overflow of the desulfuration slurry.

A dosing device for dispensing liquid from a container (1) in which flow through flow openings (23) to an outlet tube (44) is blocked after controlled delay by an obturator (3) moveable within a control chamber (2) mounted in a container neck (101) behind the outlet tube (44). Movement of the obturator (3) is governed by restricted flow through control openings (28) at the rear of the control chamber. Restoration of the obturator to the back of the control chamber facilitates repeated dosing. An elastomeric element (6) of resiliently deformable material promotes a seal to achieve a cleanly defined dose. In one proposal the elastomeric element coats the surface of the obturator and / or the outlet tube (64) to cut off the flow. Another proposal provides a one-way elastomeric valve element (63) for blocking the flow openings to enable rapid recovery after a dosing operation.

A dosing device for dispensing liquid from a container (1) in which flow through flow openings (23) to an outlet tube (44) is blocked after controlled delay by an obturator (3) moveable within a control chamber (2) mounted in a container neck (101) behind the outlet tube (44). Movement of the obturator (3) is governed by restricted flow through control openings (28) at the rear of the control chamber. Restoration of the obturator to the back of the control chamber facilitates repeated dosing. An elastomeric element (6) of resiliently deformable material promotes a seal to achieve a cleanly defined dose. In one proposal the elastomeric element coats the surface of the obturator and / or the outlet tube (64) to cut off the flow. Another proposal provides a one-way elastomeric valve element (63) for blocking the flow openings to enable rapid recovery after a dosing operation.

The invention relates to the improvement in the treatment of certain neural disorders / diseases, such as Parkinson's disease and other motor disorders. One aspect of the invention relates to drug compositions and dosage forms comprising said drug composition. Another aspect of the invention relates to methods of manufacturing the drug compositions and dosage forms. Another aspect of the invention relates to methods of treatment, comprising administering the drug composition and dosage form to an individual.

The present invention relates to active agent delivery systems and more specifically to compositions that comprise amino acids, as single amino acids or peptides, covalently attached to active agents and methods for administering conjugated active agent compositions.

The present invention generally relates to stable pharmaceutical compositions, and methods of making and administering such compositions. In one aspect, the invention features stabilized pharmaceutical compositions that include pharmaceutically active ingredients such as levothyroxine (T4) sodium and liothyronine (T3) sodium (thyroid hormone drugs), preferably in an immediate release solid dosage form. Also provided are methods for making and using such immediate release and stabilized compositions.

The subject invention provides compositions and methods of use of a single dosage form which includes therapeutic or subtherapeutic doses of a dihydropyridine calcium channel blocker (CCB), such as amlodipine, and a diuretic, preferably a thiazide-type diuretic, such as chlorthalidone.

Methods and apparatus are shown for providing information on a pill. A patient specific delivery apparatus for medicine using information on a pill or pills is shown as well, and a database with patient specific information may be provided, resulting in an individualized pharmacopoeia for a patient. A dispenser and a method for dispensing pills are provided and may generate audible messages. The dispenser may be constructed with a protective barrier to maintain shelf-life and integrity of the pills.

The present invention provides improved devices, methods, and kits for inhibiting restenosis and hyperplasia after intravascular intervention. In particular, the present invention provides controlled drug delivery in combination with x-ray radiation delivery to selected locations within a patient's vasculature to reduce and / or inhibit restenosis and hyperplasia rates with increased efficacy. In one embodiment, the combination radiation and agent delivery catheter for inhibiting hyperplasia comprises a catheter body having a proximal end and distal end, an x-ray tube coupleable to the catheter body for applying a radiation dose to a body lumen, and means coupleable to the catheter body for releasing an agent to the body lumen.

A linear accelerator head for use in a medical radiation therapy system can include a housing, an electron generator configured to emit electrons along a beam path, and a microwave generation assembly. The linear accelerator head may include a waveguide that is configured to contain a standing or travelling microwave. The waveguide can include a plurality of cells that are disposed adjacent one another, wherein each of the plurality of cells may define an aperture configured to receive electrons therethrough. The linear accelerator head can further include a converter and a primary collimator.

The present invention relates to active agent delivery systems and more specifically to compositions that comprise amino acids, as single amino acids or peptides, covalently attached to active agents and methods for administering conjugated active agent compositions.

The invention aims to provide a three-layer medical infusion bag. The three-layer medical infusion bag comprises a flat infusion bag body of a three-layer structure. The three-layer structure comprises an inner bag layer made of polyethylene material, a middle bag layer made of polypropylene and styrene-ethylene / butylene-styrene segmented copolymer material and an outer bag layer which is a blended layer of polypropylene, carboxylated styrene-ethylene / butylene-styrene segmented copolymer and anionic polymerization nylon nanocomposite. The barrier performance of the anionic polymerization nylon nanocomposite of the outer bag layer is excellent. Air inlet is not needed in the infusion process and medicine liquid can automatically flow and is completely drained through the design of the thickness and the width of the infusion bag body, and therefore the whole infusion bag is good in safety, barrier property and infusion performance. The invention further provides a manufacturing method of the three-layer medical infusion bag. One-time injection molding and air blowing are conducted through a three-die-head injection molding die, the whole process is simple and advanced, one-time forming is achieved, the method is suitable for production of the infusion bag, and the manufactured infusion bag meets the infusion requirement.

The invention belongs to the technical field of medical instruments and provides a multifunctional oncological integrated effusion drainage device. A handle is mounted on the left of the top of a support frame, a hydraulic power device that faces down is mounted on the right of the top of the support frame through a connection rack, a hydraulic telescopic bar is mounted at the bottom power end ofthe hydraulic power device, a vertical bar is connected to the bottom of the hydraulic telescopic bar and is inserted into an inner cavity of a suction barrel, the end of the vertical bar extended into the inner cavity of the suction barrel is connected with a piston, the suction barrel is arranged at the top of a negative pressure pipe, the outer wall of the left of the negative pressure pipe isconnected with the outer wall of the right of the support frame, and a one-way dredging pipe is inserted onto the right side of the negative pressure pipe. Moving wheels and the handle herein allow apatient to be conveniently moved to a proper position, and the problem that a traditional negative pressure apparatus is inconvenient to move is solved; the piston and the suction barrel are used to increase or decrease pressure in the negative pressure pipe and drain effusions, and fewer electrical devices are used.

The invention discloses a full-automatic intelligent traditional Chinese medicine slice dispenser, which comprises a housing and at least two columns of dispensing units, the dispensing units are arranged in the housing, a medicine replenishment passage is arranged between each two neighboring dispensing units, each dispensing unit comprises medicine storage boxes, linear motion modules, turnable buckets, linear feeders and a gathering passage, the dispensing units are divided into at least two layers, two columns of medicine storage boxes which are fixed on the housing are arranged oppositely on each layer, the bottom of each medicine storage box is provided with a chute, the linear feeders are mounted on the chutes, the linear motion modules are correspondingly arranged under the chutes, the turnable buckets are mounted on the linear motion modules, the gathering passages are fixed on the front of the housing, both sides of each gathering passage are respectively provided with a plurality of feed inlets corresponding to each layer of dispensing units, the bottom ends of the gathering passages are provided with discharge outlets, and a medicine receiving mechanism is arranged corresponding to the discharge outlets on the bottom of the housing. Under mechanical automatic program control, the full-automatic intelligent traditional Chinese medicine slice dispenser can conveniently load medicines and accurately meter, is quick, can be connected with a hospital information system, has high working efficiency, and saves time and manpower.

An implantable medical device charging apparatus includes a charging circuit. The charging circuit includes a series resonator responsive to a signal applied to the charging circuit. During operation, the series resonator inductively couples to a secondary coil within an implantable medical device to transfer energy to the secondary coil. The charging circuit also includes a parallel resonator coupled to the series resonator. The parallel resonator filters a first component of the signal from propagating to the series resonator.